Last reviewed · How we verify

NCT04956536

Anterior Tibial Subluxation in the Setting of ACL-injury and After ACL Reconstruction

ENROLLING BY INVITATION Last updated 22 November 2023
What this trial tests

trial testing Demographic data and MRI images were extracted and analyzed in Anterior Cruciate Ligament Injuries in 297 participants. Enrolling by invitation.

Timeline
1 December 2020
Primary endpoint
1 January 2021
1 July 2026

Quick facts

Lead sponsorPeking University Third Hospital
StatusENROLLING BY INVITATION
Study typeOBSERVATIONAL
Enrollment297
Start date1 December 2020
Primary completion1 January 2021
Estimated completion1 July 2026
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Peking University Third Hospital

Who can join

18 and older, any sex, with Anterior Cruciate Ligament Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To identify the related factors for anterior tibial subluxation (ATS) on anterior cruciate ligament-injured MRI images.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Anterior Cruciate Ligament Injuries

Currently open trials in the same condition.

Other Peking University Third Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04956536.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing